首页> 外文OA文献 >Reply to: “Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?” and “External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals”

【2h】

Reply to: “Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?” and “External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals”

机译：回复：“肝细胞癌肝癌病毒脱离后的肝细胞癌监测：肝硬化测量比实验室纤维化标记更有用吗？” “口腔抗病毒后HCV先进慢性肝病患者肝细胞癌非侵入性预测因子的外部验证”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Joan Genescà;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Changes in fibrotic markers in chronic hepatitis C patients treated with direct antiviral agents and the enhanced liver fibrosis score as a predictor of hepatocellular carcinoma [J] . Kawaguchi Toshihiro, Ide Tatsuya, Amano Keisuke, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接抗病毒治疗慢性丙型肝炎患者纤维化标志物的变化及增强肝纤维化评分作为肝细胞癌预测因子
2. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy [J] . Song Byeong G., Sinn Dong H., Chi Sangah, European journal of gastroenterology and hepatology . 2018,第12期

机译：肝硬化测量在抗病毒治疗下慢性乙型肝炎患者血清生物标志物预测的分层肝硬化癌症风险的额外作用
3. Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease [J] . Ogata Fumihiro, Kobayashi Masahiro, Akuta Norio, Oncology: International Journal of Cancer Research and Treatment . 2017,第2期

机译：关于丙型肝炎病毒基因型1相关慢性肝病患者肝细胞癌发育速率的全口头直接抗病毒方案的结果
4. Betatrophin Expression in Chronic Hepatitis C Patients: Does Contribute to Liver Injury-linked Metabolic Syndrome and Hepatocellular Carcinoma Development? [C] . Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, International Conference on Life Sciences and Technology . 2020

机译：慢性丙型肝炎患者的BERATROPHIN表达：是否有助于肝损伤链接代谢综合征和肝细胞癌发育？
5. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients [O] . Xu Li, Hongqin Xu, Pujun Gao 2019

机译：基于4个因素的纤维化指数（FIB-4）预测慢性丙型肝炎病毒（HCV）患者的肝硬化和肝细胞癌
6. External validation of non-invasive predictors of hepatocellular carcinoma in patients with HCV-related advanced chronic liver disease after oral antivirals [O] . Gamal Shiha 2020

机译：口腔抗病毒后HCV相关晚期慢性肝病患者肝细胞癌非侵入性预测因子的外部验证

著录项

相似文献

相关主题

期刊订阅